Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT

被引：3

作者：

McKay, Michael J. ^{[1
,2
,3
]}

Taubman, Kim L. ^{[4
]}

Lee, Szeting ^{[5
]}

Scott, Andrew M. ^{[2
,5
,6
]}

机构：

[1] North West Canc Ctr, Northern Canc Serv, Burnie, Tas 7320, Australia

[2] La Trobe Univ, Sch Canc Med, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia

[3] Univ Tasmania, Northwest Reg Hosp, Rural Clin Sch, Burnie, Tas 7320, Australia

[4] St Vincents Hosp, Dept Med Imaging, Fitzroy, Vic 3065, Australia

[5] Austin Hlth, Dept Mol Imaging & Therapy, 145 Studley Rd, Heidelberg, Vic 3084, Australia

[6] Univ Melbourne, Fac Med, Melbourne, Vic 3052, Australia

来源：

ANNALS OF NUCLEAR MEDICINE | 2022年 / 36卷 / 02期

关键词：

Lymphoma; Radiotherapy planning; PET; Metabolic imaging; POSITRON-EMISSION-TOMOGRAPHY; INTENSITY-MODULATED RADIOTHERAPY; STAGE HODGKIN-LYMPHOMA; INVOLVED-NODE RADIOTHERAPY; INSPIRATION BREATH-HOLD; RADIATION-THERAPY; FDG-PET; FOLLICULAR LYMPHOMA; RESPONSE ASSESSMENT; IMPACT;

D O I：

10.1007/s12149-021-01703-7

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Accurate target delineation is an absolute requirement for modern radiotherapy planning. Historically, structural imaging modalities have been used for this purpose, but there is a considerable role for functional imaging with PET/CT to contribute in this area. PET/CT's role in radiotherapy planning is well established and its use is indispensable in the clinical management of the lymphomas, particularly Hodgkin Lymphoma. A crucial use of PET/CT is as a baseline scan for delineation of the initial lymphomatous involvement, since this will determine the contouring of the gross-, clinical- and planning-target volumes (GTV, CTV, PTV). This article reviews the principles of contemporary radiotherapy, examines the evidence for the contribution of PET/CT to radiotherapy planning in lymphoma and the practicalities and challenges of applying this powerful technology to this situation.

引用

页码：162 / 171

页数：10

共 50 条

[31] USE OF PET/CT IN RADIOTHERAPY PLANNING IN LUNG CANCER
MacManus, M.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S4 - S5
[32] PET-CT IN RADIOTHERAPY PLANNING: A TECHNOLOGIST PERSPECTIVE
MacFarlane, L.
INTERNAL MEDICINE JOURNAL, 2012, 42 : 27 - 27
[33] PET-CT - Is it of any value for radiotherapy planning?
Kiil-Berthelsen, A.
RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S131 - S131
[34] PET-CT for radiotherapy planning in lung cancer
Senan, S
LUNG CANCER, 2004, 46 : S31 - S33
[35] 18F-FDG PET-CT and Radiotherapy Planning in Lung Cancer - Technical aspects and benefits from metabolic radiotherapy planning
Pinto, J.
Vieira, L.
Faria, D.
Vale, J.
Fonseca, G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S77 - S77
[36] The role of functional imaging in radiotherapy planning
Redalen, K. Roe
RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S210 - S210
[37] FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma
Letizia Deantonio
Debora Beldì
Giuseppina Gambaro
Gianfranco Loi
Marco Brambilla
Eugenio Inglese
Marco Krengli
Radiation Oncology, 3
[38] FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma
Deantonio, Letizia
Beldi, Debora
Gambaro, Giuseppina
Loi, Gianfranco
Brambilla, Marco
Inglese, Eugenio
Krengli, Marco
RADIATION ONCOLOGY, 2008, 3 (1)
[39] Direct Comparison of FAPI-PET/CT, FDG-PET/CT and conventional Imaging (CT/MRI) in Radiotherapy Planning for Head and Neck Tumors
Wegen, S.
van Heek, L.
Kunze, S.
Linde, P.
Claus, K.
Akuamoa-Boateng, D.
Baues, C.
Sharma, S. J.
Klussmann, J.
Marnitz, S.
Drzezga, A.
Kobe, C.
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S111 - S112
[40] The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
Li, Hongjia
Kong, Ziren
Xiang, Yongbo
Zheng, Rong
Liu, Shaoyan
FRONTIERS IN ONCOLOGY, 2022, 12

← 1 2 3 4 5 →